Research Papers:

Deciphering microRNA targets in pancreatic cancer using miRComb R package

Maria Vila-Casadesus, Elena Vila-Navarro, Giulia Raimondi, Cristina Fillat, Antoni Castells, Juan Jose Lozano, Meritxell Gironella _

PDF |  HTML  |  Supplementary Files  |  Order a Reprint

Oncotarget. 2018; 9:6499-6517. https://doi.org/10.18632/oncotarget.24034

Metrics: PDF 177 views  |   HTML 226 views  |   ?  


Maria Vila-Casadesús1,2, Elena Vila-Navarro1, Giulia Raimondi3, Cristina Fillat3, Antoni Castells1, Juan José Lozano1,2 and Meritxell Gironella1

1Gastrointestinal & Pancreatic Oncology Group, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain

2Bioinformatics Platform, CIBEREHD, Barcelona, Catalonia, Spain

3Gene Therapy and Cancer, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universitat de Barcelona, Barcelona, Catalonia, Spain

Correspondence to:

Meritxell Gironella, email: meritxell.gironella@ciberehd.org

Keywords: microRNA; pancreatic cancer; target prediction; gene expression; CRISPR-Cas9

Received: August 09, 2017     Accepted: January 02, 2018     Published: January 08, 2018


MiRNAs are small non-coding RNAs that post-transcriptionally regulate gene expression. They play important roles in cancer but little is known about the specific functions that each miRNA exerts in each type of cancer. More knowledge about their specific targets is needed to better understand the complexity of molecular networks taking part in cancer. In this study we report the miRNA-mRNA interactome occurring in pancreatic cancer by using a bioinformatic approach called miRComb, which combines tissue expression data with miRNA-target prediction databases (TargetScan, miRSVR and miRDB). MiRNome and transcriptome of 12 human pancreatic tissues (9 pancreatic ductal adenocarcinomas and 3 controls) were analyzed by next-generation sequencing and microarray, respectively. Analysis confirmed differential expression of both miRNAs and mRNAs in cancerous tissue versus control, and unveiled 17401 relevant miRNA-mRNA interactions likely to occur in pancreatic cancer. They were sorted according to the degree of negative correlation between miRNA and mRNA expression. Results highlighted the importance of miR-148a and miR-21 interactions among others. Two components of the Notch signaling pathway, ADAM17 and EP300, were confirmed as miR-148a targets in MiaPaca-2 pancreatic cancer cells overexpressing miR-148a. Moreover, a CRISPR-Cas9 cellular model was generated to knock-out the expression of miR-21 in PANC-1 cells. As expected, the expression of two miRComb miR-21 predicted targets, PDCD4 and BTG2, was significantly upregulated in these cells in comparison to control PANC-1.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 24034